Ann: Application for quotation of securities - BIT, page-19

I am not convinced that any announcement on the COVID results will be forthcoming at this stage. I suspect that any results were not good enough to be substantive for other parties to gender any interest. Crowded space and there are a lot of players that have had reasonably great results over the last year or so.

The HIV science looks impressive enough - but not earth shattering given that the trials added no new developments.

Just can't see what direction BIT will go in the future. HIV still looks like a promising area as is a drive into the anti-viral environment. Both will require stronger financial resources and time.

Maybe some sort of collaborative merger is the only way BIT will survive now.

A company I used to be invested with and had great potential but lost its way - changed direction and mismanaged funds got delisted yesterday.

Great management will always trump great science and lofty goals.